New research from the University of Cambridge in England shows that Vitamin D may help repair damage to myelin—the protective sheath surrounding nerve fibres—in people with multiple sclerosis (MS).
The study, published recently in the Journal of Cell Biology, provides considerable evidence that Vitamin D could eventually become a treatment option for patients with MS.
Research from the MS Society Cambridge Centre for Myelin Repairs shows that existing protein, known as the RXR receptor, connects to the Vitamin D receptor, which—as previously proven—helps to repair myelin.
Additional research is necessary to determine if lab results are effective in MS patients during clinical trials.
Roughly, 100,000 people living in Canada have multiple sclerosis. The Vitamin D Society, a Canadian non-profit group organization, encourages Canadians to protect their health by having their vitamin D levels tested on an annual basis.
